-
Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
Bond, M. J. G., van Smeden, M., Degeling, K., Cremolini, C., Schmoll, H-J., Antoniotti, C., Lonardi, S., Murgioni, S., Rossini, D., Ibach, S., Koopman, M., Swijnenburg, R-J., Punt, C. J. A., May, A. M. & Kwakman, J. J. M., 1 Jul 2024, In: JCO clinical cancer informatics. 8, e2400037.Research output: Contribution to journal › Article › Academic › peer-review
-
Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)
Kinos, S., Hagman, H., Halonen, P. I., Soveri, L-M., O'Reilly, M., Pfeiffer, P., Frödin, J-E., Sorbye, H., Heervä, E., Liposits, G., Kallio, R., Ålgars, A., Ristamäki, R., Salminen, T., Bärlund, M., Shah, C-H., McDermott, R., Röckert, R., Flygare, P., Kwakman, J., & 4 others, 2 May 2024, In: Acta oncologica (Stockholm, Sweden). 63, p. 248-258 11 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Adjuvant chemotherapy in patients with clinically node-negative but pathologically node-positive rectal cancer in the Netherlands: A retrospective analysis
Kwakman, J. J. M., Bond, M. J. G., Demichelis, R. M., Koopman, M., Hompes, R., Elferink, M. A. G. & Punt, C. J. A., 1 Jan 2024, In: European Journal of Cancer. 197, 113466.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
